Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Benner

Showing results (261-270 of 347) with videos related to

Pageof 35
Sort By:
Blood Cancer Journal|January 4, 2023
Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myelomaElias K Mai, Stefanie Huhn, Kaya Miah, et al.
Experimental Hematology & Oncology|February 15, 2017
A randomized exploratory phase 2 study in patients with chemotherapy-related peripheral neuropathy evaluating whole-body vibration training as adjunct to an integrated program including massage, passive mobilization and physical exercisesStefan S Schönsteiner, Heidi Bauder Mißbach, Axel Benner, et al.
Leukemia|October 3, 2023
Correction: Clinical impact of the genomic landscape and leukemogenic trajectories in non-intensively treated elderly acute myeloid leukemia patientsEkaterina Jahn, Maral Saadati, Pierre Fenaux, et al.
Leukemia|August 17, 2023
Clinical impact of the genomic landscape and leukemogenic trajectories in non-intensively treated elderly acute myeloid leukemia patientsEkaterina Jahn, Maral Saadati, Pierre Fenaux, et al.
International Journal of Cancer|August 4, 2023
Genome-wide study of genetic polymorphisms predictive for outcome from first-line oxaliplatin-based chemotherapy in colorectal cancer patientsHanla A Park, Dominic Edelmann, Federico Canzian, et al.
Blood|May 2, 2009
High-resolution genomic profiling of childhood T-ALL reveals frequent copy-number alterations affecting the TGF-beta and PI3K-AKT pathways and deletions at 6q15-16.1 as a genomic marker for unfavorable early treatment responseMarc Remke, Stefan Pfister, Corinne Kox, et al.
Science Immunology|July 30, 2017
Tumor-derived exosomes modulate PD-L1 expression in monocytesFranziska Haderk, Ralph Schulz, Murat Iskar, et al.
The Journal of Clinical Investigation|May 3, 2013
HPV-related methylation signature predicts survival in oropharyngeal squamous cell carcinomasEfterpi Kostareli, Dana Holzinger, Olga Bogatyrova, et al.
International Journal of Cancer|April 20, 2026
Neoadjuvant Atezolizumab and Chemotherapy for Non-Squamous Non-Small Cell Lung Cancer: Efficacy and Safety Results of an Open-Label, Single-Arm, Phase II TrialBenedikt Niedermaier, Tilmann Bochtler, Florian Eichhorn, et al.
Cancer Research|October 7, 2010
Role of LIM and SH3 protein 1 (LASP1) in the metastatic dissemination of medulloblastomaChristopher Traenka, Marc Remke, Andrey Korshunov, et al.
Pageof 35

Showing results (261-270 of 347) with videos related to

Sort By:
Pageof 35
Blood Cancer Journal|January 4, 2023
Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myelomaElias K Mai, Stefanie Huhn, Kaya Miah, et al.
Experimental Hematology & Oncology|February 15, 2017
A randomized exploratory phase 2 study in patients with chemotherapy-related peripheral neuropathy evaluating whole-body vibration training as adjunct to an integrated program including massage, passive mobilization and physical exercisesStefan S Schönsteiner, Heidi Bauder Mißbach, Axel Benner, et al.
Leukemia|October 3, 2023
Correction: Clinical impact of the genomic landscape and leukemogenic trajectories in non-intensively treated elderly acute myeloid leukemia patientsEkaterina Jahn, Maral Saadati, Pierre Fenaux, et al.
Leukemia|August 17, 2023
Clinical impact of the genomic landscape and leukemogenic trajectories in non-intensively treated elderly acute myeloid leukemia patientsEkaterina Jahn, Maral Saadati, Pierre Fenaux, et al.
International Journal of Cancer|August 4, 2023
Genome-wide study of genetic polymorphisms predictive for outcome from first-line oxaliplatin-based chemotherapy in colorectal cancer patientsHanla A Park, Dominic Edelmann, Federico Canzian, et al.
Blood|May 2, 2009
High-resolution genomic profiling of childhood T-ALL reveals frequent copy-number alterations affecting the TGF-beta and PI3K-AKT pathways and deletions at 6q15-16.1 as a genomic marker for unfavorable early treatment responseMarc Remke, Stefan Pfister, Corinne Kox, et al.
Science Immunology|July 30, 2017
Tumor-derived exosomes modulate PD-L1 expression in monocytesFranziska Haderk, Ralph Schulz, Murat Iskar, et al.
The Journal of Clinical Investigation|May 3, 2013
HPV-related methylation signature predicts survival in oropharyngeal squamous cell carcinomasEfterpi Kostareli, Dana Holzinger, Olga Bogatyrova, et al.
International Journal of Cancer|April 20, 2026
Neoadjuvant Atezolizumab and Chemotherapy for Non-Squamous Non-Small Cell Lung Cancer: Efficacy and Safety Results of an Open-Label, Single-Arm, Phase II TrialBenedikt Niedermaier, Tilmann Bochtler, Florian Eichhorn, et al.
Cancer Research|October 7, 2010
Role of LIM and SH3 protein 1 (LASP1) in the metastatic dissemination of medulloblastomaChristopher Traenka, Marc Remke, Andrey Korshunov, et al.
Pageof 35